Phibro Animal Health Corporation (NASDAQ:PAHC) Given Average Rating of “Hold” by Brokerages

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) have earned a consensus rating of “Hold” from the five brokerages that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $42.50.

A number of brokerages recently issued reports on PAHC. Zacks Research cut Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 21st. Weiss Ratings lowered Phibro Animal Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, June 15th. Citigroup reduced their price objective on Phibro Animal Health from $62.00 to $44.00 and set a “neutral” rating for the company in a research note on Thursday, May 14th. Finally, Wall Street Zen downgraded Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th.

Phibro Animal Health Stock Down 0.8%

Shares of Phibro Animal Health stock opened at $33.05 on Tuesday. The company has a quick ratio of 1.26, a current ratio of 3.17 and a debt-to-equity ratio of 1.97. Phibro Animal Health has a 52-week low of $25.58 and a 52-week high of $60.08. The company has a market capitalization of $1.34 billion, a P/E ratio of 14.18, a P/E/G ratio of 0.47 and a beta of 0.46. The company has a 50 day moving average of $32.58 and a 200 day moving average of $43.40.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.72 by $0.04. The company had revenue of $383.54 million during the quarter, compared to the consensus estimate of $367.02 million. Phibro Animal Health had a return on equity of 37.14% and a net margin of 6.35%.Phibro Animal Health has set its FY 2026 guidance at 2.980-3.100 EPS. As a group, research analysts forecast that Phibro Animal Health will post 3.08 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, June 24th. Shareholders of record on Wednesday, June 3rd were paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 1.5%. The ex-dividend date was Wednesday, June 3rd. Phibro Animal Health’s dividend payout ratio (DPR) is 20.60%.

Insiders Place Their Bets

In other news, CEO Jack Bendheim sold 7,040 shares of Phibro Animal Health stock in a transaction dated Tuesday, May 5th. The shares were sold at an average price of $55.80, for a total value of $392,832.00. Following the sale, the chief executive officer owned 67,720 shares of the company’s stock, valued at $3,778,776. The trade was a 9.42% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 32,688 shares of company stock valued at $1,759,633. Company insiders own 50.13% of the company’s stock.

Hedge Funds Weigh In On Phibro Animal Health

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Bank of America Corp DE increased its position in shares of Phibro Animal Health by 22.6% in the first quarter. Bank of America Corp DE now owns 78,957 shares of the company’s stock valued at $4,367,000 after buying an additional 14,536 shares in the last quarter. Systematic Alpha Investments LLC purchased a new position in Phibro Animal Health during the 1st quarter valued at about $293,000. Amundi purchased a new position in Phibro Animal Health during the 1st quarter valued at about $539,000. EverSource Wealth Advisors LLC raised its position in Phibro Animal Health by 19.0% during the first quarter. EverSource Wealth Advisors LLC now owns 5,907 shares of the company’s stock worth $327,000 after acquiring an additional 943 shares during the last quarter. Finally, California State Teachers Retirement System raised its position in Phibro Animal Health by 19.9% during the first quarter. California State Teachers Retirement System now owns 22,515 shares of the company’s stock worth $1,245,000 after acquiring an additional 3,735 shares during the last quarter. 99.34% of the stock is owned by institutional investors and hedge funds.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.